Skip to main content
. 2018 Jun 18;97(23):e10969. doi: 10.1097/MD.0000000000010969

Table 4.

Mean arterial pressure (MAP), heart rate (HR), and peripheral capillary oxygen saturation (SPO2) before premedication (T1), after etomidate injection (T2), after uterus expansion (T3), and after recovery from anesthesia (T4) in control patients and patients who received transcutaneous acupoint electrical stimulation (TAES) and/or low-dose sufentanil pretreatment before etomidate injection.

3.

HHS Vulnerability Disclosure